Immatics (IMTX) Receivables (2019 - 2025)
Immatics (IMTX) reported Receivables of $7.1 million for Q4 2025, up 13.43% on a YoY basis from $6.3 million in Q4 2024, and up 89.84% sequentially from $3.7 million in Q3 2025.
Immatics (IMTX) Receivables (2019 - 2025) Analysis & Trends
Immatics (IMTX) has 7 years of Receivables data on file, last reported at $7.1 million in Q4 2025.
- For the quarter ending Q4 2025, Receivables rose 13.43% year-over-year to $7.1 million; the trailing twelve-month figure through Dec 2025 stood at $7.1 million (up 13.43% YoY), and the FY2025 full-year result was $6.9 million, up 8.7% from the prior year.
- Receivables climbed to $7.1 million in Q4 2025, from $3.7 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $7.1 million in Q4 2025 to a low of $247942.0 in Q1 2023.
- A 5-year average of $2.3 million and a median of $1.1 million in 2022 frame the typical range for Receivables.
- Across the five-year window, Receivables plunged 99.88% in 2021 and soared 742.4% in 2024, its largest moves.
- Tracing IMTX's Receivables over 5 years: stood at $780188.2 in 2021, then jumped by 45.28% to $1.1 million in 2022, then jumped by 288.52% to $4.4 million in 2023, then surged by 42.12% to $6.3 million in 2024, then rose by 13.43% to $7.1 million in 2025.
- Business Quant data shows IMTX's Receivables at $7.1 million in Q4 2025, $3.7 million in Q3 2025, and $2.2 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 4.97 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 938.02 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Immatics | 1.11 Bn | 1.11 Bn | - | 7.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.10 Mn |
| Sep 30, 2025 | 3.74 Mn |
| Jun 30, 2025 | 2.22 Mn |
| Mar 31, 2025 | 5.89 Mn |
| Dec 31, 2024 | 6.26 Mn |
| Sep 30, 2024 | 3.24 Mn |
| Jun 30, 2024 | 3.03 Mn |
| Mar 31, 2024 | 1.93 Mn |
| Dec 31, 2023 | 4.40 Mn |
| Sep 30, 2023 | 559,535.51 |
| Jun 30, 2023 | 359,345.05 |
| Mar 31, 2023 | 247,941.96 |
| Dec 31, 2022 | 1.13 Mn |
| Sep 30, 2022 | 1.15 Mn |
| Jun 30, 2022 | 1.03 Mn |
| Mar 31, 2022 | 832,774.59 |
| Dec 31, 2021 | 780,188.19 |
| Sep 30, 2021 | 854,983.31 |
| Jun 30, 2021 | 864,666.89 |
| Mar 31, 2021 | 693,585.76 |